Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045458404> ?p ?o ?g. }
- W2045458404 endingPage "388" @default.
- W2045458404 startingPage "375" @default.
- W2045458404 abstract "A method based on active-site affinity chromatography on soybean trypsin inhibitor (SBTI)-Sepharose was developed for isolation of human factor Xa in primarily the undergraded alpha-form. The chromatography procedure separated factor Xa from factor X, the Russel's viper venom proteinase used to activate factor X, and traces of contaminating thrombin. alpha-Factor Xa was unstable at pH 7.6 and 25 degrees C, undergoing slow proteolytic degradation to functionally heterogeneous products as evidenced by the greater loss of coagulation assay activity compared to activity measured with a chromogenic substrate. The results of monitoring factor Xa degradation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis were consistent with proteolysis of the light chain as a major component reaction occurring in parallel with slower proteolysis of the heavy chain. The decreased rates of these reactions at pH 6.0 enabled isolation and storage of factor Xa in greater than or equal to 88% alpha-form and minimized the heterogeneity due to proteolytic degradation. Characterization of the reaction of fluorescein mono-p-guanidinobenzoate (FMGB) with human and bovine factor Xa isolated by SBTI-Sepharose chromatography demonstrated its utility as a sensitive reagent for continuous fluorometric active-site titration. Analysis of the reaction kinetics as a function of FMGB and human factor Xa concentrations in G/2 0.3, pH 7.4, buffer at 25 degrees C indicated that the ratio of acylation to deacylation rate constants was greater than 200 and that the Km for FMGB was 0.06-0.11 microM, predicting pre-steady-state burst amplitudes of greater than or equal to 96-98% of the active-site concentration at FMGB concentrations greater than or equal to 5 microM. Human factor Xa active-site concentrations were consistent with 82-99% active preparations when compared with the protein concentrations determined from the 280-nm absorbance. Concentrations of human alpha-factor Xa as low as 20 nM could be measured with FMGB, indicating a sensitivity approximately 50 times greater than that measured by spectrophotometric active-site titration with p-nitophenyl p'-guanidinobenzoate." @default.
- W2045458404 created "2016-06-24" @default.
- W2045458404 creator A5046718241 @default.
- W2045458404 creator A5055990354 @default.
- W2045458404 creator A5059797329 @default.
- W2045458404 creator A5081039413 @default.
- W2045458404 date "1989-09-01" @default.
- W2045458404 modified "2023-09-26" @default.
- W2045458404 title "Isolation of human blood coagulation α-factor Xa by soybean trypsin inhibitor-Sepharose chromatography and its active-site titration with fluorescein mono-p-guanidinobenzoate" @default.
- W2045458404 cites W142999592 @default.
- W2045458404 cites W1482160007 @default.
- W2045458404 cites W1488573465 @default.
- W2045458404 cites W1490507833 @default.
- W2045458404 cites W1505723334 @default.
- W2045458404 cites W1519085965 @default.
- W2045458404 cites W152180060 @default.
- W2045458404 cites W1522778435 @default.
- W2045458404 cites W1524888592 @default.
- W2045458404 cites W1537378853 @default.
- W2045458404 cites W1561293009 @default.
- W2045458404 cites W1590468510 @default.
- W2045458404 cites W1618720360 @default.
- W2045458404 cites W1969631009 @default.
- W2045458404 cites W1978899774 @default.
- W2045458404 cites W1984445610 @default.
- W2045458404 cites W1990512900 @default.
- W2045458404 cites W199055613 @default.
- W2045458404 cites W1995135269 @default.
- W2045458404 cites W1998681536 @default.
- W2045458404 cites W1999504433 @default.
- W2045458404 cites W2001257332 @default.
- W2045458404 cites W2016305546 @default.
- W2045458404 cites W2020221662 @default.
- W2045458404 cites W2024851569 @default.
- W2045458404 cites W2026360066 @default.
- W2045458404 cites W2028897053 @default.
- W2045458404 cites W2029037118 @default.
- W2045458404 cites W2032279957 @default.
- W2045458404 cites W2038264300 @default.
- W2045458404 cites W2062618848 @default.
- W2045458404 cites W2091317550 @default.
- W2045458404 cites W2100837269 @default.
- W2045458404 cites W2128788780 @default.
- W2045458404 cites W2333160546 @default.
- W2045458404 cites W2475211548 @default.
- W2045458404 cites W2809943451 @default.
- W2045458404 cites W4251685699 @default.
- W2045458404 doi "https://doi.org/10.1016/0003-9861(89)90496-7" @default.
- W2045458404 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2774557" @default.
- W2045458404 hasPublicationYear "1989" @default.
- W2045458404 type Work @default.
- W2045458404 sameAs 2045458404 @default.
- W2045458404 citedByCount "85" @default.
- W2045458404 countsByYear W20454584042013 @default.
- W2045458404 countsByYear W20454584042014 @default.
- W2045458404 crossrefType "journal-article" @default.
- W2045458404 hasAuthorship W2045458404A5046718241 @default.
- W2045458404 hasAuthorship W2045458404A5055990354 @default.
- W2045458404 hasAuthorship W2045458404A5059797329 @default.
- W2045458404 hasAuthorship W2045458404A5081039413 @default.
- W2045458404 hasConcept C116084860 @default.
- W2045458404 hasConcept C141814087 @default.
- W2045458404 hasConcept C178790620 @default.
- W2045458404 hasConcept C179247698 @default.
- W2045458404 hasConcept C181199279 @default.
- W2045458404 hasConcept C184866935 @default.
- W2045458404 hasConcept C185592680 @default.
- W2045458404 hasConcept C193363816 @default.
- W2045458404 hasConcept C2776351012 @default.
- W2045458404 hasConcept C2779881004 @default.
- W2045458404 hasConcept C2780340462 @default.
- W2045458404 hasConcept C2781307694 @default.
- W2045458404 hasConcept C43617362 @default.
- W2045458404 hasConcept C55493867 @default.
- W2045458404 hasConceptScore W2045458404C116084860 @default.
- W2045458404 hasConceptScore W2045458404C141814087 @default.
- W2045458404 hasConceptScore W2045458404C178790620 @default.
- W2045458404 hasConceptScore W2045458404C179247698 @default.
- W2045458404 hasConceptScore W2045458404C181199279 @default.
- W2045458404 hasConceptScore W2045458404C184866935 @default.
- W2045458404 hasConceptScore W2045458404C185592680 @default.
- W2045458404 hasConceptScore W2045458404C193363816 @default.
- W2045458404 hasConceptScore W2045458404C2776351012 @default.
- W2045458404 hasConceptScore W2045458404C2779881004 @default.
- W2045458404 hasConceptScore W2045458404C2780340462 @default.
- W2045458404 hasConceptScore W2045458404C2781307694 @default.
- W2045458404 hasConceptScore W2045458404C43617362 @default.
- W2045458404 hasConceptScore W2045458404C55493867 @default.
- W2045458404 hasIssue "2" @default.
- W2045458404 hasLocation W20454584041 @default.
- W2045458404 hasLocation W20454584042 @default.
- W2045458404 hasOpenAccess W2045458404 @default.
- W2045458404 hasPrimaryLocation W20454584041 @default.
- W2045458404 hasRelatedWork W2065372645 @default.
- W2045458404 hasRelatedWork W2068841117 @default.
- W2045458404 hasRelatedWork W2096290293 @default.
- W2045458404 hasRelatedWork W2124040392 @default.
- W2045458404 hasRelatedWork W2303072007 @default.